Login

Financial Snapshot

Revenue
TTM
$671.0K
Gross Margin
TTM
86.71%
Net Income
TTM
-$1.141M
Current Assets
2023 Q3
Current Liabilities
2023 Q3
Current Ratio
2023 Q3
10.33%
Total Assets
2023 Q3
Total Liabilities
2023 Q3
Book Value
2023 Q3
-$1.391M
Cash
2023 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$317.0K

Stock Price

Loading...
Market Cap: $240 Thousand

About Manuka, Inc.

Manuka, Inc. is a biopharmaceutical company. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. The company regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.

Industry: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics Peers: NUNZIA PHARMACEUTICAL Co Bonk Inc Integrated Biopharma Inc Estee Lauder Companies Inc Genufood Energy Enzymes Corp. Zivo Bioscience Inc Mannatech Inc TWINLAB CONSOLIDATED HOLDINGS, INC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support